Cynata Therapeutics Limited

ASX:CYP.AX

0.22 (AUD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q22008 Q12007 Q42007 Q32007 Q2
Revenue -0.232.546-0.1471.8010.86.9711.5190.0272.5624.45-01.309-0.0771.452-0.0251.7740.0871.0120.2420.04300.02500.0080.0340.04100.0410.0410.05600.0560.0560.02800.0280.02800000.08800.0880.0880000
Cost of Revenue 0.140.140.140.140.140.140.140.140.140.140.140000000000000.0020.0090.1300.130.130.09700.0970.0970.08500.0850.0850.00300.0030.0030.08300.0830.0830000
Gross Profit -0.372.405-0.2871.6610.666.8311.379-0.1122.4224.309-0.141.309-0.0771.452-0.0251.7740.0871.0120.2420.04300.02500.0060.025-0.090-0.09-0.09-0.0420-0.042-0.042-0.0560-0.056-0.056-0.0030-0.003-0.0030.00500.0050.0050000
Gross Profit Ratio 1.610.9451.9540.9220.8250.980.908-4.0920.9450.968560.9281111111110100.7440.744-2.210-2.21-2.21-0.7470-0.747-0.747-1.9840-1.984-1.98400000.05700.0570.0570000
Reseach & Development Expenses 8.962012.67409.10504.05806.205.93203.503.47304.15501.9200.50300.09100000000000000000000000000
General & Administrative Expenses 000000000000000000000000.1740.1740.22700.2270.2270.61800.6180.6180.45900.4590.4590.14600.1460.1460.28800.2880.2880000
Selling & Marketing Expenses 00000000000000000000000-0.13-0.13-0.2120-0.212-0.212-0.6070-0.607-0.607-0.4420-0.442-0.4420.04700.0470.047-0.0380-0.038-0.0380000
SG&A 3.8936.9469.1716.8345.0387.9624.284.8183.5786.7115.4833.2941.272.4040.9132.1951.8762.8970.0211.2810.6131.2980.0560.0440.1380.01500.0150.0150.01100.0110.0110.01700.0170.0170.19400.1940.1940.2500.250.250000
Other Expenses 000006.938000-0.222000000000000000000000000000000000000000
Operating Expenses 12.8556.9469.1716.8345.0381.0244.284.8183.5786.9345.4834.4192.8163.2683.6012.7962.7063.4812.6251.4621.371.7770.5520.0440.4250.01500.0150.0150.01100.0110.0110.01700.0170.0170.19400.1940.1940.2500.250.250000
Operating Income -13.085-7.087-9.311-6.974-5.178-1.164-4.42-4.958-3.719-7.074-5.623-3.11-2.94-1.816-3.562-1.021-2.614-2.468-2.557-1.419-1.37-1.752-0.448-0.212-0.4-0.4360-0.436-0.436-0.6740-0.674-0.674-0.5330-0.533-0.533-0.3440-0.344-0.344-0.5340-0.534-0.5340000
Operating Income Ratio 56.874-2.78463.47-3.872-6.476-0.167-2.911-180.333-1.452-1.5922,490-2.37638.115-1.25140.26-0.576-29.924-2.438-10.555-32.7240-69.9250-24.972-11.776-10.7240-10.724-10.724-12.0850-12.085-12.085-18.7190-18.719-18.7190000-6.090-6.09-6.090000
Total Other Income Expenses Net 7.8810.230.2060.1470.8640.0331.570.1180.1184.5260.1310.1290.1900.0300.14200.26300.0580.025-0.087-0.0170.0190.0500.050.050.03200.0320.0320.00400.0040.004-0.0190-0.019-0.0190.02500.0250.0250000
Income Before Tax -5.204-6.857-9.104-6.827-4.314-1.131-2.85-4.84-3.601-2.549-5.492-2.981-2.75-1.816-3.532-1.021-2.471-2.468-2.293-1.419-1.312-1.728-0.535-0.229-0.381-0.3860-0.386-0.386-0.6410-0.641-0.641-0.5290-0.529-0.529-0.3630-0.363-0.363-0.5090-0.509-0.5090000
Income Before Tax Ratio 22.618-2.69362.064-3.791-5.395-0.162-1.877-176.036-1.406-0.57321,966-2.27735.655-1.25139.073-0.576-28.295-2.438-9.468-32.7240-68.9420-26.961-11.206-9.4940-9.494-9.494-11.5050-11.505-11.505-18.5830-18.583-18.5830000-5.8050-5.805-5.8050000
Income Tax Expense 0-2.316-0-1.654-0-0-0-0-2.510-0000000000000000.0500.050.050.03400.0340.0340.00700.0070.007-0.0160-0.016-0.0160.02600.0260.0260000
Net Income -5.204-4.541-9.104-5.173-4.314-1.131-2.85-4.84-1.09-2.549-5.492-2.981-2.75-1.816-3.532-1.021-2.471-2.468-2.293-1.419-1.312-1.728-0.535-0.229-0.381-0.3860-0.386-0.386-0.6410-0.641-0.641-0.5290-0.529-0.529-0.3630-0.363-0.363-0.5090-0.509-0.5090000
Net Income Ratio 22.618-1.78462.064-2.872-5.395-0.162-1.877-176.036-0.426-0.57321,966-2.27735.655-1.25139.073-0.576-28.295-2.438-9.468-32.7240-68.9420-26.961-11.206-9.4940-9.494-9.494-11.5050-11.505-11.505-18.5830-18.583-18.5830000-5.8050-5.805-5.8050000
EPS -0.029-0.025-0.062-0.036-0.03-0.008-0.02-0.041-0.01-0.025-0.054-0.03-0.03-0.02-0.041-0.014-0.034-0.034-0.035-0.026-0.024-0.049-0.021-0.01-0.018-0.0410-0.041-0.041-0.130-0.13-0.13-0.140-0.14-0.14-0.110-0.11-0.11-0.150-0.15-0.150000
EPS Diluted -0.029-0.025-0.062-0.036-0.03-0.008-0.02-0.041-0.01-0.025-0.054-0.03-0.03-0.02-0.041-0.014-0.034-0.034-0.035-0.026-0.024-0.049-0.021-0.01-0.018-0.0410-0.041-0.041-0.130-0.13-0.13-0.140-0.14-0.14-0.110-0.11-0.11-0.150-0.15-0.150000
EBITDA -5.549-6.946-9.171-6.834-5.038-1.024-4.28-4.818-3.578-6.934-5.483-2.97-2.8-1.676-3.422-0.881-2.473-2.328-2.109-1.419-1.37-1.752-0.445-0.229-0.397-0.2820-0.282-0.282-0.6370-0.637-0.637-0.5260-0.526-0.526-0.3580-0.358-0.358-0.5060-0.506-0.5060000
EBITDA Ratio 24.119-2.72962.516-3.795-6.301-0.147-2.819-175.242-1.397-1.55821,930-2.26936.3-1.154134.748-0.497-28.317-2.299-8.706-32.7220-69.9240-26.932-11.696-6.9370-6.937-6.937-11.4220-11.422-11.422-18.4630-18.463-18.4630000-5.7780-5.778-5.7780000